Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Assessment of Humacyte's Human Acellular Vessel in Patients Needing Renal Replacement Therapy: A Comparison With ePTFE Grafts as Conduits for Hemodialysis (HUMANITY)

NCT02644941 is registered in ClinicalTrials.gov with Humacyte, Inc. as lead sponsor.

NCT NCT02644941
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02644941 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Assessment of Humacyte's Human Acellular Vessel in Patients Needing Renal Replacement Therapy: A Comparison With ePTFE Grafts as Conduits for Hemodialysis (HUMANITY)
Lead sponsor
Humacyte, Inc.
Phase
Phase 3
Overall status
Completed
Start date
May 24, 2016
Completion date
September 30, 2023
Enrollment
355 (actual)
Sites
38

Conditions

As the registry lists them; a condition with its own page is linked.

end stage renal disease, hemodialysis, renal failure, vascular access